Luigi di Biase, MD
Cardiovascular Disease · Bronx, NYNPI 1891045837
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $603,432 of the $977,576 with a category attached, or 61.7%. 21 manufacturers reported payments, led by Biosense Webster, Inc. at 40.6% of the total. 2025 is the largest year on record at $320,216, 3.0 times the $105,916 reported in 2019. Among cardiovascular disease clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 990 payments — averaging $987.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biosense Webster, Inc.$397K
- Medical Device Business Services, Inc.$190K
- Biotronik Inc.$142K
- Boston Scientific$106K
- Medtronic$63K
- Abbott$20K
- plus $59K from 15 others
Across 2,457 payments — averaging $618.91 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medical Device Business Services, Inc.$401K
- Biotronik Inc.$354K
- Biosense Webster, Inc.$304K
- Boston Scientific$241K
- Medtronic$188K
- Atricure, Inc.$32K
What the payments were for
- Consulting fees$603,43262%
- Speaking & faculty fees$186,81319%
- Travel & lodging$141,99015%
- Food & beverage$45,3285%
- Education$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biosense Webster, Inc. | 323 | $397,030 |
| Medical Device Business Services, Inc. | 69 | $190,206 |
| Biotronik Inc. | 173 | $141,706 |
| Boston Scientific | 157 | $106,287 |
| Medtronic(2 entities) | 162 | $62,541 |
| Abbott | 44 | $20,498 |
| Stereotaxis Inc | 5 | $19,200 |
| Irhythm Technologies, Inc. | 4 | $9,125 |
| Siemens Medical Solutions USA, Inc. | 8 | $8,694 |
| Baylis Medical Company Inc | 14 | $8,461 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 6 | $6,000 |
| Cardiva Medical, Inc. | 8 | $4,482 |
| Atricure, Inc. | 3 | $2,291 |
| Impulse Dynamics (USA) Inc. | 2 | $280 |
| Abiomed | 1 | $150 |
| Philips North America LLC | 1 | $142 |
| Janssen Scientific Affairs, LLC | 1 | $138 |
| Acutus Medical, Inc. | 1 | $106 |
| Medicomp Inc | 1 | $86 |
| Sanofi-aventis U.S. LLC | 3 | $81 |
| E.r. Squibb & Sons, L.L.C. | 4 | $72 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$437,130
- Carto 3 System$68,057
- Farapulse$50,113
- Sentus$22,082
- VersaCross Access Solution$21,638
- Niobe$19,200
- Rivacor$15,301
- Edora$15,301
- Acticor$15,301
- Plexa$13,000
- ZIO XT Patch$9,125
- Thermocool SF$8,483
- ACUSON Origin Diagnostic Ultrasound System$8,004
- LifeVest$6,000
- Watchman$5,752
- GENERAL - THERAPIES$5,724
- GENERAL EP$5,188
- Cardiva VASCADE MVP VVCS 6-12F$4,281
- Arctic Front$4,210
- GENERAL VASCULAR ACCESS$4,000
How this compares
$977,576 in reported general payments places this provider in the 95th percentile of 2,302 cardiovascular disease providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 147 | $101,072 |
| XareltoRivaroxaban | 43 | $31,223 |
| Amiodarone Hcl | 60 | $1,873 |
| Matzim LaDiltiazem Hcl | 11 | $638 |
| Metoprolol Succinate | 44 | $288 |
| Metoprolol Tartrate | 35 | $113 |
| Furosemide | 12 | $6 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Bronx
- Joseph HelftBronx$488K
- Roger HajjarNew York$5.2M
- Szilard VorosStony Brook$3.7M
- Gregg StoneNew York$2M
- Augustin DelagoAlbany$1.8M
- Philippe GenereuxNew York$1.3M
- Adam RosenbluthNew York$1.1M
- Vijay IyerAmherst$855K
- Megha PrasadNew York$813K
- Ronald DagostinoLake Success$782K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.